AURKA is aberrantly expressed in a wide range of human cancers, including breast cancer 12, ovarian cancer 13, cervical cancer 14, and hepatocellular carcinoma 15, and the aberrant expression of AURKA correlates with poor prognosis. Here, AURKA is linked to ovarian carcinoma.